Company profile
Skye Bioscience, Inc.
NASDAQ:SKYEBiotechnology: Pharmaceutical Preparations
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT06144918 | phase2 | completed | 2023-11-09 | 2024-02-22 | Skye Bioscience, Inc. | Ph2 Placebo-Controlled Study for Safety & Ocular Efficacy of SBI-100 Ophthalmic Emulsion in Pts w/ Elevated Eye Pressure |
| NCT06577090 | phase2 | active_not_recruiting | 2024-08-22 | 2026-11-20 | Skye Bioscience, Inc. | Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo |
FDA applications (0)
No records yet.